Trial
NCT05028569
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
AbbVie
Collaborators
—
Condition
Episodic Migraine
Intervention
BOTOX
Why stopped
The study was terminated early due to lack of efficacy from the primary analysis results.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-09